Long-term Extension Study to Evaluate the Safety of Dutog... | NCT01101945 | Trialant

Long-term Extension Study to Evaluate the Safety of Dutog... | NCT01101945 | Trialant

Outcomes Module

Primary Outcomes

Measure	Description	Time Frame
To demonstrate safety and tolerability of dutogliptin/PHX1149T as assessed by vital signs, adverse event reporting, and routine clinical laboratory assessments		104 weeks
To demonstrate safety and tolerability of dutogliptin/PHX1149Tas assessed by vital signs, adverse event reporting, and routine clinical laboratory assessments		208 weeks (U.S. only)